Showing 1881-1890 of 3035 results for "".
MelaFind in Practice: Real-Time Insights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melafind-in-practice-real-time-insights/22969/MelaFind helps dermatologists to be more accurate, but it also serves the dual function of preventing unnecessary biopsies.Expert Panel Consensus on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus
https://practicaldermatology.com/issues/june-2024/expert-panel-consensus-on-uniform-nomenclature-and-diagnosis-for-neuropathic-pruritus/26549/Dr. Peter Lio and colleagues look at a 2023 article working to establish a consensus on uniform nomenclature and diagnosis for neuropathic pruritis.Global Aesthetics Trends: 5 Take-aways
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/global-aesthetics-trends-5-take-aways/23795/New data on the global aesthetics market show there’s expansion in sheer patient volume as well as in who is seeking cosmetic treatments.Key Lessons for Surviving COVID-19 as a Dermatologist
https://practicaldermatology.com/topics/practice-management/key-lessons-for-surviving-covid-19-as-a-dermatologist/23405/Here are 10 lessons we learned about crisis preparedness from leading dermatologists.Update on Non-invasive Gene Expression Testing for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-non-invasive-gene-expression-testing-for-melanoma/20341/A simple patch-style test may help support the need to biopsy suspicious lesions.Innovation Station
https://practicaldermatology.com/topics/practice-management/innovation-station/20751/CES 2017 unveils a host of digital health tools.Teledermatology Two Ways
https://practicaldermatology.com/topics/practice-management/teledermatology-two-ways/20912/As telemedicine grows, dermatology is adapting the practice to benefit patients and physicians.How to Evaluate EHRs in a Switcher's Market
https://practicaldermatology.com/topics/practice-management/how-to-evaluate-ehrs-in-a-switchers-market/21031/Six questions that can help potential users evaluate a product's value.EHR Choices: Work Smarter, Not Harder
https://practicaldermatology.com/topics/practice-management/ehr-choices-work-smarter-not-harder/21285/Assessing Clinical Options for Moderately Dysplastic Nevi Excised with Positive Margins
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-clinical-options-for-moderately-dysplastic-nevi-excised-with-positive-margins/20322/The latest data support the decision to monitor patients rather than re-excise when the pathology report confirms moderate dysplasia with positive margins.